FDA Inspection 1221082 — South Texas Blood and Tissue Center
The FDA completed an inspection of South Texas Blood and Tissue Center on October 18, 2023 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 18, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- San Antonio, TX (United States)